Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study

Dong Wan Kim, Byoung Chul Cho, Krishna Pachipala, Sang We Kim, Chih Liang Wang, Gee Chen Chang, Myung Ju Ahn, Rosa Alvarez, Chao Hua Chiu, José Trigo, Anna Estival, Sana D. Karam, Cathy O'Brien, Hema Gowda, Haiyi Jiang, Julie E. Bauman

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science